SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042129
Filing Date
2021-08-06
Accepted
2021-08-06 16:01:56
Documents
81
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-10q_20210630.htm   iXBRL 10-Q 2541349
2 EX-31.1 eypt-ex311_7.htm EX-31.1 15974
3 EX-31.2 eypt-ex312_9.htm EX-31.2 16187
4 EX-32.1 eypt-ex321_6.htm EX-32.1 5536
5 EX-32.2 eypt-ex322_10.htm EX-32.2 5623
  Complete submission text file 0001564590-21-042129.txt   9608899

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eypt-20210630.xsd EX-101.SCH 75916
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20210630_cal.xml EX-101.CAL 51497
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20210630_def.xml EX-101.DEF 258714
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20210630_lab.xml EX-101.LAB 518794
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20210630_pre.xml EX-101.PRE 413871
11 EXTRACTED XBRL INSTANCE DOCUMENT eypt-10q_20210630_htm.xml XML 1852404
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 211152829
SIC: 3826 Laboratory Analytical Instruments